Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Deal Watch: Takeda Continues Transaction Spree With Four More Deals

Aug 04 2017

• By Joseph Haas and Lubna Ahmed

DealWatch_1200x675

Related Content

US FDA Shows Relaxed Approach On Personalized Medicine In Zejula Approval

Mar 30 2017

Takeda-Advinus R&D Alliance ‘Closed’

Aug 02 2017

NeuroDerm Makes Progress On Simplified Path To Parkinson's Approval

Mar 06 2017

The PARP Combo Race Is On: Clovis And Bristol Partner On Rubraca

Jul 31 2017

Fosun’s Gland Acquisition Faces Indian Wall?

Aug 01 2017

Pfizer Hits Pause On M&A To See How US Tax Reform Plays

Aug 01 2017

A Whopper Of A Deal: AZ Hands Half Of Lynparza To Merck

Jul 27 2017

Will Mitsubishi's High Offer Price For CNS Target NeuroDerm Deter Others?

Jul 24 2017

Gilead Buys Nimbus NASH Drug To Dominate Another Liver Disease

Apr 05 2016

Related Companies

Takeda Pharmaceutical Co. Ltd.

Tesaro, Inc.

AstraZeneca PLC

Merck & Co., Inc.

Clovis Oncology, Inc.

Bristol Myers Squibb Company

Cardurion Pharmaceuticals Inc.

Isogenica Ltd.

Schrodinger, Inc.

Pfizer Inc.

Sanofi

Nimbus Therapeutics, Inc.

Gilead Sciences, Inc.

Gilead Sciences, Inc.

Eurofins Advinus Limited

Mitsubishi Tanabe Pharma Corporation

NeuroDerm, Ltd.

LadRx Corporation

NantWorks, LLC

Seagen Inc.

Genentech, Inc.

Alligator Bioscience AB

Aptevo Therapeutics Inc.

Opus Bio

Miltenyi Biomedicine

Living Pharma Inc.

BriaCell Therapeutics Corp.

BriaCell Therapeutics Corp.

Amo Pharma Limited

Shanghai Henlius Biotech Co. Ltd.

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Additional Topics

Commercial Deals M & A Business Strategies BioPharmaceutical

More from Business

More from Scrip

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window